Journal of Public HealthHessel L (2008) The contribution of vaccine manufacturers to the establishment of vaccination policies J Public Health (Suppl) (to be completed)Hessel, L. (2008). The contribution of vaccine manufacturers to the establishment of vaccination policies. J public health 16:299...
However, the ability to stop outbreaks with nOPV2 is dependent on the implementation of timely, high-quality outbreak response of sufficient scope. CRediT authorship contribution statement Grace Macklin: Methodology, Visualization, Writing – original draft, Writing – review & editing. Corey Peak: ...
It is suggested that despite subsequent changes in vaccine technology, their different incentive structure requires acknowledgement in current discussion of the potential contribution of public sector vaccine institutes to vaccine innovation. 展开 关键词: lock in vaccine development polio vaccine ...
In November 2011, a Royal Society discussion meeting, 'New vaccines for global health', was held in London to discuss the past contribution of vaccines to global health and to consider what more could be expected in the future. Papers presented at the meeting reviewed recent successes in the ...
However, the dramatic vaccine divide cannot simply be reversed by China's contribution, experts said, calling for the US and other countries to act to balance vaccine distribution to achieve global herd immunity. The AP quoted Masiyiwa as saying that Africa needs 1.6 billion doses in a double-...
Nature Human Behaviour thanks the anonymous reviewers for their contribution to the peer review of this work. Peer reviewer reports are available. Additional information Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. ...
In contrast, a therapeutic KSHV vaccine to prevent cancer development regardless of prior infection may have public health importance to protect high-risk individuals (MSM or potential organ recipients) in low-prevalence countries. Whether women should be considered for vaccination in low prevalence ...
From a public health perspective, it is the overall effect (that is, a combination of both direct and indirect effects) that should be considered to fully evaluate an intervention’s impact. This composite effect of vaccination is not readily assessed by clinical trials, though some have tried ...
We also thank the Ottawa Methods Centre at The Ottawa Hospital Research Institute for their contribution to this publication. Sample receipt and serological assays were conducted at the University of Ottawa Serology and Diagnostic High Throughput Facility. Production of COVID-19 reagents was financially...
Additional Contributions: Study authors graciously acknowledge the contribution of participants and clinical, regulatory, and research staff at VBI Vaccines Inc. References 1. Ghaswalla PK, Patterson BJ, Cheng WY, Duchesneau E, Macheca M, Duh MS. Hepatitis A, B, and A/B...